Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Oct 5, 2025
Transactions
9
Purchases
1
Sales
8
Purchase value
$275.50K
Sale value
$2.64M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Dillione JanetDirector
4Rule 10b5-1 plan disclosed
Filed Jan 22, 2026Period of report Jan 21, 20260001213900-26-006876
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 21, 2026
Common StockF1
10,000
$6.88
$68.80K
38,473
Direct
Filing footnotes · 1
F1This transaction was executed in multiple trades at prices ranging from $6.85 to $6.90, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected
Filed Jan 2, 2026Period of report Dec 30, 20250001213900-26-000712
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Todisco JosephDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Dec 19, 2025Period of report Dec 18, 20250001213900-25-124063
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Dillione JanetDirector
4Rule 10b5-1 plan disclosed
Filed Dec 11, 2025Period of report Dec 9, 20250001213900-25-120378
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Lefkowitz Steven WDirector
4
Filed Dec 10, 2025Period of report Dec 9, 20250001213900-25-120296
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 9, 2025
Common StockF1
40,000
$11.88
$475.20K
80,498
Direct
Dillione JanetDirector
4Rule 10b5-1 plan disclosed
Filed Dec 4, 2025Period of report Dec 2, 20250001213900-25-118433
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Dillione JanetDirector
4
Filed Nov 26, 2025Period of report Nov 24, 20250001213900-25-115725
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 24, 2025
Common StockF1
26,343
$9.93
$261.59K
48,473
Direct
Dillione JanetDirector
4
Filed Nov 18, 2025Period of report Nov 14, 20250001213900-25-112316
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 14, 2025
Common StockF1
30,000
$11.42
$342.60K
48,473
Direct
Kaplan MyronDirector
4
Filed Oct 27, 2025Period of report Oct 23, 20250001213900-25-102764
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseOct 23, 2025
Common StockF1
25,000
$11.02
$275.50K
201,034
Direct
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.
Dec 30, 2025
Common Stock
20,000
$13.00
$260.00K
40,250
Direct
Filing footnotes · 1
F1These options were granted on 2/22/2022. These options are fully vested.
F1This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2These options were granted on 01/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F1This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected
F2These options were granted on 02/21/2016. These options are fully vested.
F3These options were granted on 02/25/2020. These options are fully vested.
F1This transaction was executed in multiple trades at prices ranging from $11.87 to $11.92, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2The Reporting Person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which the Reporting Person has voting and investment control).
F1This transaction was executed in multiple trades at prices ranging from $9.72 to $10.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2These options were granted on 02/16/2018. These options are fully vested.
F3These options were granted on 02/22/2022. These options are fully vested.
F4These options were granted on 01/14/2023. These options are fully vested.
F5These options were granted on 03/05/2024. These options are fully vested.
F1This transaction was executed in multiple trades at prices ranging from $11.41 to $11.44, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.01 to $11.03, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
